Jim Flynn - Building a Healthcare Investment Platform Across Public, Private, and Venture

Healthcare investing requires a multidisciplinary approach that bridges the gap between scientific innovation and financial viability. Jim Flynn, managing partner of Deerfield Management, advocates for a holistic strategy that integrates public equity, venture capital, and non-profit initiatives to address systemic healthcare challenges. By utilizing a "fail cheap" model in drug discovery and leveraging deep data moats, firms can improve the probability of success in complex fields like oncology and anti-infectives. Artificial intelligence is poised to revolutionize the sector by shifting diagnostic power to patients and streamlining clinical development through advanced protein mapping. Successful investment in this space demands a long-term, probabilistic mindset, exemplified by the strategic turnaround of distressed assets like Melinta and the development of breakthrough therapies such as those seen in the New Valent portfolio, ultimately aligning private returns with meaningful improvements in human welfare.